Skip to content

Biodesix, Inc. BDSX Cash Flow Statement

FY'25FY'24FY'23FY'22
-$35.27M+17.9%-$42.93M+17.7%-$52.15M+20.3%-$65.45M-51.6%
$5.67M-1.8%$5.77M+73.5%$3.33M-7.5%$3.6M+13.2%
$4.14M-37.6%$6.64M+23.5%$5.37M-9.9%$5.96M+20.6%
-$24.05M+50.6%-$48.65M-104%-$23.81M+47.1%-$44.97M-53.4%
$259K-92.0%$3.23M-85.9%$22.92M+595%$3.3M+47.2%
-$403K+88.3%-$3.44M+85.1%-$23.06M-553%-$3.53M-38.8%
$21K-58.8%$51K+4.1%$49K-99.8%$28.94M-36.3%
$16.42M-68.6%$52.23M+79.3%$29.13M-52.4%$61.15M
-$39K$10.38M+134%
-$24.22M+53.3%-$51.88M-13.3%-$45.79M+5.1%-$48.27M-54.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Biodesix, Inc. generate?
Biodesix, Inc. (BDSX) generated -$25.6M in operating cash flow over the trailing twelve months.
What is Biodesix, Inc.'s free cash flow?
After $266.0K of capital expenditures, Biodesix, Inc.'s free cash flow was -$25.8M over the trailing twelve months, up 42.7% year over year.
Where does Biodesix, Inc.'s cash flow data come from?
Every line is extracted from Biodesix, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.